HLA-DRB1 typing by micro-bead array assay identifies the origin of early lymphoproliferative disorder in a heart transplant recipient

Am J Transplant. 2013 Mar;13(3):802-7. doi: 10.1111/ajt.12063. Epub 2013 Jan 17.

Abstract

We report the case of a 68-year-old woman who underwent heart transplantation for hypertrophic cardiomyopathy. Two months after the transplant she developed mild fever and dyspnea with a marked drop in left ventricle ejection fraction of 31%. Coronary angiography was negative for cardiac allograft vasculopathy. Endomyocardial biopsy revealed ischemic damage with no evidence of acute cellular rejection, antibody-mediated rejection or viral myocarditis. A neoplastic process was suspected even though full-body computerized tomography was negative for malignancy. The patient died 4 months after transplantation. The autopsy showed acute antero-septal myocardial infarction due to a nodular epicardial EBV-related posttransplant lymphoproliferative disorder (PTLD) infiltrating the left anterior descending coronary artery with occlusive neoplastic thrombosis. We highlight two major aspects of this case: (1) the unusual occurrence of early PTLD involving the cardiac allograft and causing a fatal outcome, (2) the application of an immunological technique for HLA-DRB1 typing to posttransplant paraffin-embedded autopsy material to identify the recipient origin of this early malignancy, thus excluding a possible donor-transmitted neoplasm.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Cardiomyopathy, Hypertrophic / complications
  • Cardiomyopathy, Hypertrophic / surgery*
  • Cardiomyopathy, Hypertrophic / virology
  • DNA, Viral / genetics
  • Epstein-Barr Virus Infections / complications
  • Epstein-Barr Virus Infections / virology
  • Fatal Outcome
  • Female
  • Graft Rejection / diagnosis*
  • Graft Rejection / etiology
  • HLA-DRB1 Chains / genetics*
  • Heart Transplantation / adverse effects*
  • Herpesvirus 4, Human / isolation & purification
  • Histocompatibility Testing
  • Humans
  • Lymphoproliferative Disorders / diagnosis*
  • Lymphoproliferative Disorders / etiology
  • Oligonucleotide Array Sequence Analysis
  • Postoperative Complications*

Substances

  • DNA, Viral
  • HLA-DRB1 Chains